Thieme Holm, Morkisch Nadine, Mehrholz Jan, Pohl Marcus, Behrens Johann, Borgetto Bernhard, Dohle Christian
Erste Europäische Schule für Physiotherapie, Ergotherapie und Logopädie, Klinik Bavaria Kreischa, Kreischa, Sachsen, Germany.
Cochrane Database Syst Rev. 2018 Jul 11;7(7):CD008449. doi: 10.1002/14651858.CD008449.pub3.
Mirror therapy is used to improve motor function after stroke. During mirror therapy, a mirror is placed in the person's midsagittal plane, thus reflecting movements of the non-paretic side as if it were the affected side.
To summarise the effectiveness of mirror therapy compared with no treatment, placebo or sham therapy, or other treatments for improving motor function and motor impairment after stroke. We also aimed to assess the effects of mirror therapy on activities of daily living, pain, and visuospatial neglect.
We searched the Cochrane Stroke Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL, AMED, PsycINFO and PEDro (last searched 16 August 2017). We also handsearched relevant conference proceedings, trials and research registers, checked reference lists, and contacted trialists, researchers and experts in our field of study.
We included randomised controlled trials (RCTs) and randomised cross-over trials comparing mirror therapy with any control intervention for people after stroke.
Two review authors independently selected trials based on the inclusion criteria, documented the methodological quality, assessed risks of bias in the included studies, and extracted data. We assessed the quality of the evidence using the GRADE approach. We analysed the results as standardised mean differences (SMDs) or mean differences (MDs) for continuous variables, and as odds ratios (ORs) for dichotomous variables.
We included 62 studies with a total of 1982 participants that compared mirror therapy with other interventions. Of these, 57 were randomised controlled trials and five randomised cross-over trials. Participants had a mean age of 59 years (30 to 73 years). Mirror therapy was provided three to seven times a week, between 15 and 60 minutes for each session for two to eight weeks (on average five times a week, 30 minutes a session for four weeks).When compared with all other interventions, we found moderate-quality evidence that mirror therapy has a significant positive effect on motor function (SMD 0.47, 95% CI 0.27 to 0.67; 1173 participants; 36 studies) and motor impairment (SMD 0.49, 95% CI 0.32 to 0.66; 1292 participants; 39 studies). However, effects on motor function are influenced by the type of control intervention. Additionally, based on moderate-quality evidence, mirror therapy may improve activities of daily living (SMD 0.48, 95% CI 0.30 to 0.65; 622 participants; 19 studies). We found low-quality evidence for a significant positive effect on pain (SMD -0.89, 95% CI -1.67 to -0.11; 248 participants; 6 studies) and no clear effect for improving visuospatial neglect (SMD 1.06, 95% CI -0.10 to 2.23; 175 participants; 5 studies). No adverse effects were reported.
AUTHORS' CONCLUSIONS: The results indicate evidence for the effectiveness of mirror therapy for improving upper extremity motor function, motor impairment, activities of daily living, and pain, at least as an adjunct to conventional rehabilitation for people after stroke. Major limitations are small sample sizes and lack of reporting of methodological details, resulting in uncertain evidence quality.
镜像疗法用于改善中风后的运动功能。在镜像疗法中,一面镜子被放置在人体的正中矢状平面,从而将非瘫痪侧的动作反射出来,就好像它是患侧一样。
总结与不治疗、安慰剂或假治疗或其他治疗相比,镜像疗法在改善中风后运动功能和运动障碍方面的有效性。我们还旨在评估镜像疗法对日常生活活动、疼痛和视觉空间忽视的影响。
我们检索了Cochrane中风小组试验注册库、Cochrane对照试验中央注册库(CENTRAL)、MEDLINE、Embase、CINAHL、AMED、PsycINFO和PEDro(最后检索时间为2017年8月16日)。我们还手工检索了相关会议论文集、试验和研究注册库,检查了参考文献列表,并联系了我们研究领域的试验者、研究人员和专家。
我们纳入了将镜像疗法与中风后患者的任何对照干预措施进行比较的随机对照试验(RCT)和随机交叉试验。
两位综述作者根据纳入标准独立选择试验,记录方法学质量,评估纳入研究的偏倚风险,并提取数据。我们使用GRADE方法评估证据质量。对于连续变量,我们将结果分析为标准化均数差(SMD)或均数差(MD),对于二分变量,分析为比值比(OR)。
我们纳入了62项研究,共1982名参与者,这些研究将镜像疗法与其他干预措施进行了比较。其中,57项为随机对照试验,5项为随机交叉试验。参与者的平均年龄为59岁(30至73岁)。镜像疗法每周进行3至7次,每次15至60分钟,共进行2至8周(平均每周5次,每次30分钟,共4周)。与所有其他干预措施相比,我们发现中等质量的证据表明镜像疗法对运动功能有显著的积极影响(SMD 0.47,95%CI 0.27至0.67;1173名参与者;36项研究)和运动障碍(SMD 0.49,95%CI 0.32至0.66;1292名参与者;39项研究)。然而,对运动功能的影响受对照干预类型的影响。此外,基于中等质量的证据,镜像疗法可能改善日常生活活动(SMD 0.48,95%CI 0.30至0.65;622名参与者;19项研究)。我们发现低质量的证据表明对疼痛有显著的积极影响(SMD -0.89,95%CI -1.67至-0.11;248名参与者;6项研究),而对改善视觉空间忽视没有明确效果(SMD 1.06,95%CI -0.10至2.23;175名参与者;5项研究)。未报告不良反应。
结果表明,有证据支持镜像疗法在改善中风后患者上肢运动功能、运动障碍、日常生活活动和疼痛方面的有效性,至少可作为传统康复的辅助手段。主要局限性在于样本量小以及缺乏方法学细节的报告,导致证据质量不确定。